Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Smilek

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1991
An immune response defect due to low levels of class II cell surface expression. Analysis of antigen presentation and positive selectionS Gilfillan, S Aiso, D Smilek, et al.
Neurocase|September 11, 2002
Synaesthesia: a case study of discordant monozygotic twinsD Smilek, B A Moffatt, J Pasternak, et al.
Transplantation|April 1, 1992
Evidence that tolerance to cultured thyroid allografts is an active immunological process. Protection of third-party grafts bearing new antigens when associated with tolerogenic antigensF G La Rosa, D Smilek, D W Talmage, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1991
An immune response defect due to low levels of class II cell surface expression. Analysis of antigen presentation and positive selectionS Gilfillan, S Aiso, D Smilek, et al.
Neurocase|September 11, 2002
Synaesthesia: a case study of discordant monozygotic twinsD Smilek, B A Moffatt, J Pasternak, et al.
Transplantation|April 1, 1992
Evidence that tolerance to cultured thyroid allografts is an active immunological process. Protection of third-party grafts bearing new antigens when associated with tolerogenic antigensF G La Rosa, D Smilek, D W Talmage, et al.
Pageof 2